Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck

Low potential of circulating interleukin 1 receptor antagonist as a prediction marker for squamous cell carcinoma of the head and neck

Background: Circulating markers are attractive molecules for prognosis and management of cancer that allow sequential monitoring of patients during and after treatment. Based on previous protein profiling data, circulating interleukin 1 receptor antagonist (IL-1Ra) was evaluated as a potential diagn...

Full description

Bibliographic Details
Main Authors:	Boldrup, L. (Author), Coates, P. (Author), Fåhraeus, R. (Author), Gu, X. (Author), Nylander, K. (Author), Sgaramella, N. (Author), Wang, L. (Author), Wilms, T. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	adult age aged Article body mass cancer prognosis cancer staging Carcinoma, Squamous Cell cohort analysis comparative study controlled study electrochemiluminescence immunoassay female Head and Neck Neoplasms head and neck squamous cell carcinoma head and neck tumor human Humans IL-1Ra interleukin 1 receptor Interleukin 1 Receptor Antagonist Protein interleukin 1 receptor blocking agent major clinical study male middle aged people by smoking status plasma predictive value Receptors, Interleukin-1 squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck tongue carcinoma tumor volume upregulation very elderly
Online Access:	View Fulltext in Publisher

Similar Items

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab
by: Madelyn Espinosa-Cotton, et al.
Published: (2019-07-01)

Basaloid squamous cell carcinoma of the head and neck: Our experience
by: Jaimanti Bakshi, et al.
Published: (2020-01-01)

Prevalence of Head and Neck Cancer in Gilan Province, Iran: A 10-Year Study
by: F Shahsavari, et al.
Published: (2017-07-01)

Head and neck cancers: Regional trends in Kashmir
by: Shahid Rasool, et al.
Published: (2017-01-01)

IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
by: Yi Zhao, et al.
Published: (2021-05-01)

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
by: Kedar Kirtane, et al.
Published: (2018-12-01)

The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
by: Helene Hersvik Aarstad, et al.
Published: (2020-10-01)

Field cancerization in stomatognathic system
by: Vidya Kadashetti, et al.
Published: (2016-01-01)

The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis
by: Giuseppe Troiano, et al.
Published: (2020-11-01)

Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs
by: Gilardi, M., et al.
Published: (2022)

Post-radiotherapy recurrence of conventional oral squamous cell carcinoma showing sarcomatoid components: an immunohistochemical study
by: Túlio Morandin Ferrisse, et al.
Published: (2021-01-01)

Comment from the Editor on the Special Issue “Head and Neck Critical Illness: Basic and Clinical Research Implications”
by: Hiroyuki Tomita
Published: (2019-11-01)

Specific Characteristics of Head and Neck Squamous Cell Carcinoma in Mures Area
by: Réka Fejér Enikő, et al.
Published: (2015-09-01)

Epidemiology of head and neck squamous cell carcinoma in birjand city, between 2008 and 2017
by: Leili Alizadeh, et al.
Published: (2019-07-01)

Histopathological Characteristics of Head and Neck Neoplasms in a Tertiary Care Centre in South West Punjab
by: Arnav Kr. Roychoudhury, et al.
Published: (2016-07-01)

The impact of the patient’s condition, diagnostic procedures and treatment on the survival of carcinoma of unknown primary site patients
by: Dorobisz K, et al.
Published: (2019-07-01)

Difference between Female and Male Patients with Oral Squamous Cell Carcinoma: A Single-Center Retrospective Study in Taiwan
by: Nan-Chin Lin, et al.
Published: (2020-06-01)

Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis
by: Steven F. Gameiro, et al.
Published: (2021-02-01)

Heart breaking diagnosis: Cardiac metastases from mucosal head and neck squamous cell carcinoma. Case report and review of current literature
by: Karuna Dewan, et al.
Published: (2020-11-01)

Second primary cancer in patients with head and neck squamous cell carcinoma (review of the literature)
by: G O Agabekyan, et al.
Published: (2014-06-01)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
by: Masashi Shiiba, et al.
Published: (2010-04-01)

Targeting interleukin-6 trans-signaling in head and neck squamous cell carcinoma
by: Dahl, Rachel A.
Published: (2018)

Evaluation of therapeutic efficacy with CytoSorter® circulating tumor cell–capture system in patients with locally advanced head and neck squamous cell carcinoma
by: Zheng W, et al.
Published: (2019-06-01)

Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
by: Erik Haehl, et al.
Published: (2020-02-01)

Mucin 1 regulates the hypoxia response in head and neck cancer cells
by: Kusumawadee Utispan, et al.
Published: (2021-12-01)

Highly Multiplexed Digital Spatial Profiling of the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Patients
by: Arutha Kulasinghe, et al.
Published: (2021-01-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma
by: Yao-Te Tsai, et al.
Published: (2020-05-01)

XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample
by: Yong Bae Ji, et al.
Published: (2010-03-01)

Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas
by: Yuil Kim, et al.
Published: (2020-09-01)

Association of the mir-499 polymorphisms with oral cavity and oropharyngeal squamous cell carcinoma in an Iranian population
by: Atefeh Akhani, et al.
Published: (2020-01-01)

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study
by: Zielinski Valerie, et al.
Published: (2012-02-01)

Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
by: Moonkyoo Kong, et al.
Published: (2015-12-01)

Correlation of Tissue Eosinophils with Prognosis in Head and Neck Cutaneous Squamous Cell Carcinomas
by: javad halimi, et al.
Published: (2018-10-01)

Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines
by: Eva-Leonne Göttgens, et al.
Published: (2021-03-01)

PD-L2 based immune signature confers poor prognosis in HNSCC
by: Yu Qiao, et al.
Published: (2021-01-01)

Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
by: Akash Mathur, et al.
Published: (2018-01-01)

DNA Methylation and HPV-Associated Head and Neck Cancer
by: Takuya Nakagawa, et al.
Published: (2021-04-01)

Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2018-06-01)